WELCOME TO SR VAIDYA HOLISTIC WELLNESS RESEARCH INSTITUTE

The Causes of Type 2 Diabetes: An Integrative Clinical Research Review | SR VAIDYA
Clinical Research Review

The Causes of Type 2 Diabetes
Statistics, Pathophysiology & Holistic Wellness

An Integrative Perspective on Insulin Resistance, Beta-Cell Dysfunction, Risk Factors, and the HWRi–T2D Integrated Care Model.

Prepared by A. SUDHAKAR

Qualified Ayurvedic Therapist & Panchakarma Specialist


Research Institute SR VAIDYA™

HOLISTIC WELLNESS RESEARCH INSTITUTE | SRVAIDYA.com


Integrating Ancient Wisdom for Modern Living

Abstract

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease characterized by persistent hyperglycemia arising primarily from insulin resistance and progressive impairment of pancreatic beta-cell function. It is one of the major global public-health challenges and should not be reduced to the oversimplified idea that it is caused by sugar alone. Its development reflects the interaction of genetic susceptibility, excess adiposity, physical inactivity, dietary patterns, aging, metabolic dysfunction and other environmental influences.

This review examines the principal causes and risk factors associated with T2DM, including insulin resistance, visceral adiposity, beta-cell dysfunction, prediabetes, metabolic syndrome, fatty liver disease, family history, gestational diabetes, polycystic ovary syndrome, sleep and lifestyle influences. It also discusses evidence-based prevention and proposes an HWRi–T2D Integrated Care Model emphasizing screening, assessment, identification of risk factors, correction, optimization, monitoring and empowerment.

Keywords: Type 2 Diabetes, insulin resistance, beta-cell dysfunction, obesity, visceral fat, prediabetes, metabolic syndrome, lifestyle medicine, diabetes prevention, metabolic health, holistic wellness.

01 / Introduction

Introduction

CORE PRINCIPLE: TYPE 2 DIABETES IS NOT SIMPLY A “SUGAR DISEASE.” IT IS A PROGRESSIVE DISORDER OF METABOLIC REGULATION.

Diabetes occurs when the body does not produce enough insulin, cannot effectively use the insulin it produces, or both.

In Type 2 Diabetes, the dominant processes are reduced insulin sensitivity and progressive failure of insulin secretion to compensate adequately. The disease may evolve gradually over many years and can remain clinically silent during its early metabolic stages.

02 / Global Burden

Global Burden and Statistics

The World Health Organization reports that approximately 830 million people were living with diabetes globally in 2022, representing a substantial rise compared with 1990. Type 2 Diabetes accounts for the majority of diabetes cases.

~830M
People living with diabetes globally in 2022 (WHO)
#1
Major underlying cause: Insulin Resistance + Beta-cell stress
Multi-Organ
Cardiovascular, renal, neurological & retinal risks
Indicator Significance
Global burden Approximately 830 million people living with diabetes in 2022
Trend Major increase since 1990
Major mechanisms Insulin resistance + progressive beta-cell dysfunction
Major complications Heart, brain, kidney, eye, nerve and vascular damage
03 / Physiology

Normal Glucose–Insulin Physiology

After food is digested, glucose enters the bloodstream. The pancreas releases insulin, which helps insulin-responsive tissues such as skeletal muscle and adipose tissue take up glucose, while also regulating hepatic glucose production. Glucose is then used for energy or stored, helping maintain blood glucose within a physiological range.

Food Ingestion
Bloodstream Glucose Rises
Pancreatic Insulin Release
Tissue Glucose Uptake
Euglycemia (Normal Range)
Figure 1. Normal Glucose–Insulin Physiology: Coordinated regulation between dietary glucose, pancreatic secretion, and responsive target tissues.
04 / Pathophysiology

What Goes Wrong in Type 2 Diabetes?

A common disease sequence involves insulin resistance followed by compensatory increases in insulin secretion. Over time, pancreatic beta cells experience metabolic stress and may no longer produce enough insulin to maintain normal glucose levels. The result is progressive dysglycemia and eventually persistent hyperglycemia.

Insulin Resistance
Compensatory Hyperinsulinemia
Beta-Cell Stress
Relative Insulin Deficiency
Persistent Hyperglycemia (T2DM)
05 / Central Mechanism

Insulin Resistance — The Central Mechanism

Insulin resistance means that target tissues respond less effectively to insulin. In skeletal muscle, glucose uptake is reduced; in the liver, insulin may inadequately suppress glucose production; and dysfunctional adipose tissue may contribute to altered fatty-acid metabolism and inflammatory signaling. These processes interact and can accelerate metabolic deterioration.

Figure 3. Insulin Resistance: Comparison of normal insulin action with impaired cellular glucose uptake, showing the progression toward hyperglycemia and beta-cell exhaustion.
06 / Adiposity

Overweight, Obesity and Visceral Fat

Excess body fat, particularly abdominal or visceral adiposity, is an important risk factor for Type 2 Diabetes. Visceral adipose tissue is metabolically active and may contribute to chronic low-grade inflammation, altered lipid flux and insulin resistance.

However, Type 2 Diabetes can also occur in people without obesity; genetic susceptibility, ectopic fat distribution and other metabolic factors may be important.

Figure 4. Visceral Fat → Inflammatory & Lipid Dysfunction → Insulin Resistance → Type 2 Diabetes
07 / Modifiable Factors

Physical Inactivity, Diet, Sleep & Stress

01

Physical Inactivity

Skeletal muscle is a major site of glucose disposal. Inactivity reduces insulin sensitivity, decreases energy expenditure and accelerates metabolic risk.

02

Dietary Patterns

It is scientifically incomplete to state that eating sugar alone causes T2DM. Ultra-processed foods, low fiber intake, and chronic surplus calories drive total metabolic burden.

03

Sleep & Circadian Rhythms

Poor sleep patterns and obstructive sleep apnea influence appetite regulation, hormonal balance, and tissue insulin sensitivity.

04

Chronic Stress & Smoking

Neuroendocrine activation increases cortisol and sympathetic tone, altering eating behavior and vascular/metabolic stability.

Figure 6. Lifestyle Risk Factor Pyramid: Summarizing modifiable behavioral contributors.
08 / Non-Modifiable Factors

Genetics, Family History and Age

Family history and genetic susceptibility are important non-modifiable contributors. Yet genetic risk is not destiny: genes interact with lifestyle, body composition, physical activity, dietary patterns, age and environmental exposures.

Risk generally rises with age because of body composition changes, reduced activity, and declining beta-cell reserve, though T2DM increasingly affects younger demographics.

09 / Interconnected Conditions

Prediabetes, Metabolic Syndrome & MASLD

Prediabetes (Warning Stage)

Glucose above normal but below diabetic threshold. Serves as a vital window for early lifestyle intervention to prevent progression.

Metabolic Syndrome

Cluster of central adiposity, elevated glucose, hypertension, hypertriglyceridemia, and low HDL sharing insulin-resistant pathophysiology.

Fatty Liver (MASLD)

Hepatic fat accumulation worsens hepatic insulin resistance, causing inappropriate ongoing glucose production.

Gestational Diabetes & PCOS

Prior gestational hyperglycemia and polycystic ovary syndrome indicate elevated long-term susceptibility requiring proactive monitoring.

Figure 5. Progression Pathway: Normal Metabolism → Compensatory Hyperinsulinemia → Prediabetes → Beta-Cell Failure → T2DM
10 / Complications

Complications of Persistent Hyperglycemia

Systemic Vascular & Neurological Risks

  • Cardiovascular & Cerebrovascular: Accelerated atherosclerosis, coronary heart disease, and stroke.
  • Diabetic Kidney Disease (Nephropathy): Microvascular renal damage leading to chronic kidney disease.
  • Retinopathy & Vision Loss: Retinal microvascular damage requiring routine screening.
  • Neuropathy & Lower Limb Complications: Peripheral nerve dysfunction and vascular compromise increasing ulcer/amputation risk.
11 / Prevention

Evidence-Based Prevention

Key prevention strategies include healthy dietary patterns, regular physical activity, sustainable weight management where appropriate, smoking cessation, early screening and aggressive management of prediabetes. Lifestyle interventions should be individualized and integrated with qualified medical care.

12 / Ayurveda

Ayurvedic Perspective: Prameha (Madhumeha)

Ayurvedic classical texts describe metabolic and urinary disorders under Prameha (specifically Madhumeha), recognizing dietary imbalances (Ahara), sedentary lifestyle (Vihara), and constitutional metabolic vulnerability.

A holistic approach supports comprehensive care by integrating medical assessment, nutrition, physical activity, weight management, sleep optimization, stress management and patient education.

Safety Rule: Such approaches should complement—not replace—diagnosis, prescribed medication, or evidence-based medical management.
13 / Care Model

The HWRi–T2D Integrated Care Model™

A structured, patient-centered framework integrating medical assessment, metabolic risk identification, lifestyle medicine, and sustainable self-management.

SCREEN Identify elevated risk
ASSESS HbA1c, lipids, BP & lifestyle
IDENTIFY Recognize metabolic drivers
CORRECT Address modifiable risks
OPTIMIZE Nutrition, activity & sleep
MONITOR Track clinical markers
EMPOWER Build self-management skills
Figure 8. Eight-Pillar Holistic Framework: Nutrition, Physical Activity, Weight Management, Sleep, Stress Care, Supportive Natural Approaches, Medical Care, and Education.
Nutrition
Physical Activity
Weight Balance
Sleep Hygiene
Stress Reduction
Ayurveda / Natural
Medical Care
Education
14 / Discussion

Discussion

THE BETTER QUESTION IS NOT “WHAT SINGLE FOOD CAUSED DIABETES?” BUT “WHAT COMBINATION OF METABOLIC, GENETIC AND LIFESTYLE FACTORS CONTRIBUTED TO DISEASE DEVELOPMENT?”

Type 2 Diabetes is best understood as a heterogeneous and multifactorial metabolic disease. Different individuals may reach the same diagnosis through different combinations of insulin resistance, beta-cell vulnerability, adiposity, genetics and lifestyle influences. This supports individualized prevention and management rather than simplistic single-cause explanations.

15 / Conclusion

Conclusion

Type 2 Diabetes is a progressive disorder of metabolic regulation associated with insulin resistance and progressive beta-cell dysfunction. Understanding these interacting causes creates opportunities for early detection, prevention, risk reduction and better long-term health.

EARLY DETECTION + RISK REDUCTION + EVIDENCE-BASED CARE + PATIENT EMPOWERMENT = BETTER LONG-TERM METABOLIC HEALTH

MEDICAL DIAGNOSIS PROVIDES CLARITY.
LIFESTYLE PROVIDES FOUNDATION.
HOLISTIC WELLNESS PROVIDES SUPPORT.
RESPONSIBLE REFERRAL PROVIDES SAFETY.
Clinical Disclaimer

Limitations & Disclaimer

This publication is intended for educational, academic and public-awareness purposes.

This review does not replace individualized medical diagnosis or treatment, does not prescribe medication, and does not claim that holistic wellness alone cures Type 2 Diabetes. Lifestyle and supportive holistic strategies should not replace professional medical evaluation or prescribed pharmacological diabetes management.

References

Key Scientific References

  1. World Health Organization. Diabetes Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/diabetes
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Symptoms & Causes of Diabetes. https://www.niddk.nih.gov/health-information/diabetes/overview/symptoms-causes
  3. NIDDK. Insulin Resistance & Prediabetes. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
  4. Centers for Disease Control and Prevention (CDC). Diabetes Risk Factors. https://www.cdc.gov/diabetes/risk-factors/
  5. CDC. Preventing Type 2 Diabetes. https://www.cdc.gov/diabetes/prevention-type-2/
  6. American Diabetes Association. Standards of Care in Diabetes—2026. Diagnosis and Classification of Diabetes.
  7. American Diabetes Association. Standards of Care in Diabetes—2026. Prevention or Delay of Diabetes and Associated Comorbidities.